DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLOZASIRAN IN ADULTS WITH HYPERTRIGLYCERIDEMIA (MUIR-3 STUDY)
The purpose of this research study is to look at how safe and effective ARO-APOC3 is at lowering triglycerides in people with hypertriglyceridemia. Hypertriglyceridemia is a condition where there is too much of a certain kind of fat (called triglycerides) in the blood.
Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults with Severe Hypertriglyceridemia (SHASTA-3 Study)
The purpose of this research study is to look at how safe and effective ARO-APOC3 is at lowering triglycerides in people with severe hypertriglyceridemia. Hypertriglyceridemia is a condition where there is too much of a certain kind of fat (called triglycerides) in the blood. In this study, one group of participants receives ARO-APOC3, while a second group receives placebo, which looks the same but contains no actual ARO-APOC3. You will have a 2-in-3 (66%) chance of receiving ARO-APOC3 and a 1-in-3 (33%) chance of receiving placebo.
Double Vision | NYU Langone Health
NYU Langone specialists provide expert diagnosis and treatment for people experiencing double vision, also known as diplopia.
Dr. Chanelle Coble-Sadaphal, Pediatrician and Adolescent Medicine Specialist | NYU Langone Health
A rare genetic condition shaped Dr. Chanel A. Coble-Sadaphal’s interest in adolescent medicine at Hassenfeld Children’s Hospital at NYU Langone.
Dr. Elizabeth Raetz, Director of Pediatric Hematology–Oncology | NYU Langone Health
NYU Langone’s Dr. Elizabeth A. Raetz pursued a career in pediatric hematology–oncology after losing her grandparents to cancer.
Dr. Jason Fisher, Pediatric Surgeon | NYU Langone Health
Dr. Jason C. Fisher’s interest in taking things apart and reassembling them helped him become a skilled pediatric surgeon at NYU Langone.
Dr. Jeffrey Wisoff, Director of Pediatric Neurosurgery | NYU Langone Health
Dr. Jeffrey H. Wisoff’s childhood fascination with medicine led to a career treating complex pediatric brain tumors at NYU Langone.
Dr. Mary Pat Gallagher, Director of the Pediatric Diabetes Center | NYU Langone Health
Dr. Mary Pat Gallagher, director of NYU Langone’s Pediatric Diabetes Center, believes it takes a village to support a child with diabetes.
Dr. Mikhail Kazachkov, Chief of Pediatric Pulmonary Medicine | NYU Langone Health
NYU Langone’s Dr. Mikhail Kazachkov believes the only way to treat some of the most complex breathing conditions is with a team of experts.
Dr. Ralph S. Mosca, Director of Congenital Heart Surgery | NYU Langone Health
Dr. Ralph S. Mosca works with children and their families as he treats pediatric congenital heart conditions at NYU Langone.